SCHEMBL7746346

SCHEMBL7746346

NC(=O)C(c1ccccc1)N1Cc2ccccc2C1=O

nearest known ligand 0.78

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.78
KDM4E B2RXH2 1/20 0.78
ALDH1A1 P00352 1/20 0.78
TSHR P16473 1/20 0.78
XIAP P98170 1/20 0.78
HKDC1 Q2TB90 1/20 0.78
HSD17B10 Q99714 1/20 0.78
TDP1 Q9NUW8 1/20 0.78
L3MBTL1 Q9Y468 1/20 0.78
THRB P10828 5/20 0.67
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
EGFR P00533 1/20 0.57
LMNA P02545 2/20 0.56
MAPT P10636 2/20 0.55
GAA P10253 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17357510 0.88 ALOX15 (1.00) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL31278555 0.88 ALOX15 (1.00) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL7741515 0.88 ALOX15 (1.00) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL18360796 0.88 ALOX15 (1.00) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL17357512 0.87 ALOX15 (0.81) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL21473574 0.87 ALOX15 (0.81) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL30046742 0.86 ALOX15 (0.59) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL23706154 0.82 KDM4E (0.72) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL18360794 0.82 KDM4E (0.72) ALOX15KDM4EALDH1A1TSHRXIAP
SCHEMBL21473669 0.82 THRB (0.79) ALOX15KDM4EALDH1A1TSHRXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698579-A INHIBITOR OF TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 1997-12-16 US claimed
CN-112236422-B Quinazoline compound as EGFR three-mutation inhibitor and application thereof 华东理工大学 2023-05-16 CN disclosed
CN-110372666-B Quinazoline compound as EGFR (epidermal growth factor receptor) triple mutation inhibitor and application thereof 华东理工大学 2022-11-08 CN disclosed
EP-3778586-A1 QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF East China University of Science and Technology (CN) 2021-02-17 EP disclosed
US-6200987-B1 ADMINISTERING AS TUMOR NECROSIS FACTOR INHIBITORS; CACHEXIA, ENDOTOXIN SHOCK; RETROVIRUS VIRICIDES CELGENE CORPORATION 2001-03-13 US disclosed
US-6075041-A TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 2000-06-13 US disclosed
US-5877200-A Cyclic amides CELGENE CORPORATION (US) 1999-03-02 US disclosed
US-5698579-A INHIBITOR OF TUMOR NECROSIS FACTOR CELGENE CORPORATION (US) 1997-12-16 US disclosed